Company profile
Gennady Nikitin company profile
Gennady Nikitin developed a novel fluorescent mitochondrial pH probe to identify the metabolic profiles of various cancers. These phenotypes can then be used to screen metabolism-targeting anti-cancer drugs, to discover which will be most effective against each type of cancer. Finding metabolic profiles that are unique to cancerous cells, and absent in healthy cells, will be of special interest.
Business identity
- Operating status
- Active
- Company type
- For Profit
Headquarters
- Headquarters
- Bulle, Fribourg, Switzerland
- Country code
- CH
- Continent
- Europe